CASI Pharmaceuticals
CASI
CASI was delisted on the 25th of February, 2026.
85 hedge funds and large institutions have $127M invested in CASI Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 5 closing their positions.
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 16
16% more funds holding
Funds holding: 73 → 85 (+12)
4% more capital invested
Capital invested by funds: $122M → $127M (+$5.21M)
0.45% more ownership
Funds ownership: 3.34% → 3.8% (+0.45%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.85M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$8.32M |
| 3 |
TLP
Tri Locum Partners
New York
|
+$4.21M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.55M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$1.83M |
Top Sellers
| 1 |
Northern Trust
Chicago,
Illinois
|
-$336K |
| 2 |
Morgan Stanley
New York
|
-$144K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$133K |
| 4 |
Millennium Management
New York
|
-$124K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$100K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MAM
76
Meeder Asset Management
Dublin,
Ohio
| $10K | +$11.4K | +407 | New |
|
77
Bank of Montreal
Toronto,
Ontario, Canada
| $5K | -$23.4K | -833 | -79% |
|
78
Osaic Holdings
Scottsdale,
Arizona
| $5K | – | – | – |
|
79
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $4K | – | – | – |
|
|
FF
80
FourThought Financial
Venice,
Florida
| $1K | – | – | – |
|
81
Fidelity Investments
Boston,
Massachusetts
| $1K | +$1.52K | +54 | +5,400% |
|
|
AIG
82
American International Group
New York
| $92 | +$281 | +10 | +0.3% |
|
|
83
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$133K | -4,506 | Closed |
|
|
CS
84
Credit Suisse
Zurich,
Switzerland
| – | -$57K | -1,941 | Closed |
|
|
ZCM
85
Zebra Capital Management
Stamford,
Connecticut
| – | -$33K | -1,118 | Closed |
|
|
CFGS
86
Concourse Financial Group Securities
Birmingham,
Alabama
| – | -$393 | -14 | Closed |
|
|
RWB
87
RMR Wealth Builders
Montclair,
New Jersey
| – | +$56 | +2 | New |
|
|
SFS
88
Sowell Financial Services
North Little Rock,
Arkansas
| – | +$702 | +25 | New |
|
CASI Hedge Fund Activity: Q1 2021 in Review
85 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in CASI Pharmaceuticals (CASI) for Q1 2021, worth a combined $127M — up 4.3% from $122M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CASI positions and 5 closed out — a net gain of 13 holders — while 32 added to existing stakes and 16 trimmed.
The largest buyer was Federated Hermes, adding an estimated $8.85M. The largest seller was Northern Trust, cutting an estimated $336K.
- 85 institutional investors held CASI Pharmaceuticals (CASI) as of Q1 2021, up from 73 in Q4 2020.
- Funds reported $127M of CASI Pharmaceuticals stock for Q1 2021, up 4.3% quarter-over-quarter.
- 18 funds opened new CASI Pharmaceuticals positions in Q1 2021 and 5 closed out, a net change of +13 holders.
- The largest CASI Pharmaceuticals buyer in Q1 2021 was Federated Hermes, an estimated $8.85M added.
- The largest CASI Pharmaceuticals seller in Q1 2021 was Northern Trust, an estimated $336K sold.
Based on aggregated 13F filings for Q1 2021.